Regression of B-Cell Lymphoma of the Liver with Hepatitis C Virus Infection After Treatment with Pegylated Interferon-α and Ribavirin

• Published in: Digestive diseases and sciences Vol. 55; no. 6; pp. 1791 - 1793
• Main Authors: Oda, Yayoi, Kou, Tadayuki, Watanabe, Masaki, Sakuma, Yojiro, Taguchi, Nori, Kato, Yoko, Kudo, Yasushi, Yamauchi, Atsushi, Sugiura, Yasushi, Ohashi, Shinya, Asada, Masanori, Fukunaga, Toyokazu, Kawaguchi, Kiyotaka, Ito, Hiroaki, Nakamura, Takefumi, Yazumi, Shujiro
• Format: Journal Article
• Language: English
• Published: Boston Boston : Springer US 01.06.2010; Springer US; Springer
• Subjects: Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Antiviral Agents - therapeutic use; Biochemistry; Biological and medical sciences; Biopsy; Case Report; Chemotherapy, Adjuvant; Drug Therapy, Combination; Feeding. Feeding behavior; Female; Fundamental and applied biological sciences. Psychology; Gastroenterology; Hematologic and hematopoietic diseases; Hepatitis C - complications; Hepatitis C - diagnosis; Hepatitis C - drug therapy; Hepatology; Human viral diseases; Humans; Infectious diseases; Interferon-alpha - therapeutic use; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Liver Neoplasms - diagnosis; Liver Neoplasms - drug therapy; Liver Neoplasms - radiotherapy; Liver Neoplasms - virology; Lymphoma, B-Cell - diagnosis; Lymphoma, B-Cell - drug therapy; Lymphoma, B-Cell - radiotherapy; Lymphoma, B-Cell - virology; Magnetic Resonance Imaging; Medical sciences; Medicine; Medicine & Public Health; Neoplasm Staging; Oncology; Radiotherapy, Adjuvant; Ribavirin - therapeutic use; Transplant Surgery; Treatment Outcome; Vertebrates: anatomy and physiology, studies on body, several organs or systems; Viral diseases; Viral hepatitis; HCV; Interferon; Lymphoma; Ribavirin; Alpha interferon; Liver; Hepatic disease; Metabolic diseases; Malignant hemopathy; Infection; Treatment; Lymphoproliferative syndrome; Viral disease; Gastroenterology; Nucleoside analog; Digestive diseases; Antiviral; Cancer; Viral hepatitis C
• ISSN: 0163-2116; 1573-2568
• DOI: 10.1007/s10620-009-0902-5